ARMANDO ANIDO
CIK 1219866 · Chairman & Chief Exec. Officer · last filed 2025-06-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.27M
Companies
7
Total Filings
70
Lifetime Open-Market Net
-$3.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 71,000 | $4.23 | $300.3K | $31.2K | 11 | 2025-06-30 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Chairman & Chief Exec. Officer | 0 | $1.30 | $0 | $130.0K | 17 | 2023-10-11 |
| AVIR | Director | — | $4.49 | — | $0 | 2 | 2017-05-22 |
| Vaxart, Inc. (BOTA) Delisted | Director | — | — | — | $0 | 1 | 2015-10-21 |
| PATH | Chief Executive Officer | 1,270,000 | $10.55 | $13.40M | $0 | 4 | 2013-01-22 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | CEO & President | 77,267 | — | — | -$3.71M | 26 | 2011-10-11 |
| RPRX | Director | 10,450 | $54.87 | $573.4K | $0 | 5 | 2010-05-19 |
Recent Filings · Page 3 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-28 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-23 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2018-08-07 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Buy (P) | +15,000 | $89.4K | EDGAR |
| 2018-01-16 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-22 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2017-05-16 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Buy (P) | +5,000 | $98.5K | EDGAR |
| 2017-01-26 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-13 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2015-10-21 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-10 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Conv (C) | +39,892 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.